Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. PEREZ-ROMERO N, Campos-Jara C, Pesce C, Araya Sierralta S, et al
    Effects of physical exercise on executive functions of individuals with schizophrenia spectrum disorders: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0296273.
    >> Share

  2. CLEMMENSEN L, Lund CN, Andresen BS, Midtgaard J, et al
    Study protocol for RUFUS-A randomized mixed methods pilot clinical trial investigating the relevance and feasibility of rumination-focused cognitive behavioral therapy in the treatment of patients with emergent psychosis spectrum disorders.
    PLoS One. 2024;19:e0297118.
    >> Share

  3. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    >> Share

  4. ROSADO D, Intriago B, Loor E, Alcivar F, et al
    Associations between Toxoplasma gondii seropositivity and psychopathological manifestations in schizophrenic patients: A single-center study from Ecuador.
    PLoS One. 2024;19:e0297523.
    >> Share

  5. FEIJS HME, van Aken L, van der Veld WM, van der Heijden PT, et al
    No relations between executive functions and dimensional models of psychopathology or is time the missing link?
    PLoS One. 2024;19:e0288386.
    >> Share


  6. Expression of Concern: Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.
    PLoS One. 2024;19:e0301152.
    >> Share

  7. LIU J, Sun SJ, Lu Y, Ping X, et al
    Taste dysfunction as a predictor of depression in schizophrenia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0300935.
    >> Share

  8. BASU A, Dutta AK, Bagepally BS, Das S, et al
    Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers.
    PLoS One. 2024;19:e0300511.
    >> Share

  9. MUSLIH M, Chung MH
    Structural validity of the Rosenberg self-esteem scale in patients with schizophrenia in Indonesia.
    PLoS One. 2024;19:e0300184.
    >> Share

  10. HANLON C, Roberts T, Misganaw E, Malla A, et al
    Studying the context of psychoses to improve outcomes in Ethiopia (SCOPE): Protocol paper.
    PLoS One. 2024;19:e0293232.
    >> Share


  11. Correction: Integrated bioinformatics and statistical approach to identify the common molecular mechanisms of obesity that are linked to the development of two psychiatric disorders: Schizophrenia and major depressive disorder.
    PLoS One. 2024;19:e0304339.
    >> Share

  12. HASSANZADEH R, Abrol A, Pearlson G, Turner JA, et al
    A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.
    PLoS One. 2024;19:e0293053.
    >> Share

  13. RAHMAN A, Russell M, Zheng W, Eckrich D, et al
    SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).
    PLoS One. 2024;19:e0295891.
    >> Share

  14. EGGER JR, Kaaya S, Swai P, Lawala P, et al
    Functioning and quality of life among treatment-engaged adults with psychotic disorders in urban Tanzania: Baseline results from the KUPAA clinical trial.
    PLoS One. 2024;19:e0304367.
    >> Share

  15. FASSLER L, Bighelli I, Leucht S, Sabe M, et al
    Targeted psychological and psychosocial interventions for auditory hallucinations in persons with psychotic disorders: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0306324.
    >> Share

  16. WANG Y, Bi S, Li X, Zhong Y, et al
    Perturbations in gut microbiota composition in schizophrenia.
    PLoS One. 2024;19:e0306582.
    >> Share

  17. KOLIND ME, Kruse R, Petersen AS, Larsen CS, et al
    Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial.
    PLoS One. 2024;19:e0306408.
    >> Share

  18. MATHIS WS, Ferrara M, Cahill J, Karmani S, et al
    TimelinePTC: Development of a unified interface for pathways to care collection, visualization, and collaboration in first episode psychosis.
    PLoS One. 2024;19:e0302116.
    >> Share

  19. HUSAIN MO, Hawke LD, Lu Y, Kozloff N, et al
    A mixed-methods study to evaluate the feasibility and preliminary efficacy of delivering the optimal health program (OHP) for youth at clinical high risk (CHR) for psychosis: A study protocol.
    PLoS One. 2024;19:e0306968.
    >> Share

  20. FITZGERALD I, Sahm LJ, Howe J, Maidment I, et al
    Shared decision-making interventions in the choice of antipsychotic prescription in people living with psychosis (SHAPE): Protocol for a realist review.
    PLoS One. 2024;19:e0304626.
    >> Share

  21. REQUENA SS, Loch AA, Mendes KN, Reavley NJ, et al
    Development of mental health first aid guidelines for psychosis for Brazil: A Delphi expert consensus study.
    PLoS One. 2024;19:e0307064.
    >> Share

  22. OSTERGAARD FG, Penninx BWJH, Das N, Arango C, et al
    The aperiodic exponent of neural activity varies with vigilance state in mice and men.
    PLoS One. 2024;19:e0301406.
    >> Share

  23. MIEDLICH SU, Sahay P, Olivares TE, Lamberti JS, et al
    Lifestyle and mood correlates of cardiometabolic risk in people with serious mental illness on second-generation antipsychotic medications.
    PLoS One. 2024;19:e0306798.
    >> Share

  24. MUSLIH M, Chung MH
    Correction: Structural validity of the Rosenberg self-esteem scale in patients with schizophrenia in Indonesia.
    PLoS One. 2024;19:e0308836.
    >> Share

  25. HALLAJIAN AH, Sharifi K, Rostami R, Saeed F, et al
    Neurocognitive effects of 3 mA prefrontal electrical stimulation in schizophrenia: A randomized sham-controlled tDCS-fMRI study protocol.
    PLoS One. 2024;19:e0306422.
    >> Share

  26. BOSWORTH ML, Isles AR, Wilkinson LS, Humby T, et al
    Sex-dependent effects of Setd1a haploinsufficiency on development and adult behaviour.
    PLoS One. 2024;19:e0298717.
    >> Share

  27. LIM MJH, Iyyalol R, Lee JWY, Martin-Iverson MT, et al
    Multi-modal and bi-directional effects of a synthetic Delta9-Tetrahydrocannabinol (THC) analogue, Nabilone, on spatio-temporal binding windows: Evidence from the projected hand illusion.
    PLoS One. 2024;19:e0309614.
    >> Share

  28. PU J, Wang B, Wang Y
    Validity of handgrip strength for assessing cognition and psychotic symptoms in hospitalized patients with stable schizophrenia.
    PLoS One. 2024;19:e0308133.
    >> Share

  29. TYAS TH, Good MD, Pratikno B, Subandi MA, et al
    Unlocking the mentally ill in Indonesia: An empirical study of the effectiveness of a "Bebas Pasung" program in Central Java.
    PLoS One. 2024;19:e0302190.
    >> Share

  30. WANG B, Zhou Y, Yu H, Jiang T, et al
    Correlations between nutritional indicators and cognitive function in patients with stable schizophrenia in a hospital setting.
    PLoS One. 2024;19:e0312227.
    >> Share

  31. ROOSENSCHOON BJ, Deen ML, van Weeghel J, Kamperman AM, et al
    Illness (self) management, clinical and functional recovery as determinants of personal recovery in people with severe mental illnesses: A mediation analysis.
    PLoS One. 2024;19:e0313202.
    >> Share

    January 2023
  32. LI S, Otsuka I, Tanifuji T, Okazaki S, et al
    Ribosomal DNA gene copies are increased in blood and brain of Japanese schizophrenia patients.
    PLoS One. 2023;18:e0280694.
    >> Share

  33. BYRNE MK, Easpaig BNG, Gray R, Creek R, et al
    Behavioural activation for depressive symptoms in young people with emerging or early psychosis: A pilot study protocol.
    PLoS One. 2023;18:e0280559.
    >> Share

  34. LONGARDNER K, Wright BA, Alakkas A, You H, et al
    Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
    PLoS One. 2023;18:e0278262.
    >> Share

  35. COHEN LS, Vanderkruik R, Arakelian M, Church TR, et al
    Establishment of the MGH Postpartum Psychosis Project: MGHP3.
    PLoS One. 2023;18:e0281133.
    >> Share

  36. MIDDLETON CURRAN L, Sheridan Rains L, Taylor J, Morant N, et al
    Acceptability and feasibility of using contingency management for cannabis reduction in specialist mental health services for psychosis: A qualitative study of staff views.
    PLoS One. 2023;18:e0281368.
    >> Share

  37. HANCOCK F, Rosas FE, McCutcheon RA, Cabral J, et al
    Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology.
    PLoS One. 2023;18:e0282707.
    >> Share

  38. FEI X, Wang S, Li J, Wang J, et al
    The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: Protocol for an updated systematic review and meta-analysis.
    PLoS One. 2023;18:e0283185.
    >> Share

  39. XAVIER RM, Shanavas Y, Britt BM, George WT, et al
    Influences of race and clinical variables on psychiatric genetic research participation: Results from a schizophrenia sample.
    PLoS One. 2023;18:e0284356.
    >> Share

  40. XU F, Xian Z
    Study investigating executive function in schizophrenia patients and their unaffected siblings.
    PLoS One. 2023;18:e0285034.
    >> Share

  41. RAJAGOPALAN A, Lim KWK, Tan XW, Martin D, et al
    Predictors of cognitive changes in patients with schizophrenia undergoing electroconvulsive therapy.
    PLoS One. 2023;18:e0284579.
    >> Share

  42. MIZUTANI R, Saiga R, Yamamoto Y, Uesugi M, et al
    Structural aging of human neurons is opposite of the changes in schizophrenia.
    PLoS One. 2023;18:e0287646.
    >> Share

  43. ROTENBERG M, Gozdyra P, Anderson KK, Kurdyak P, et al
    The role of geography and distance on physician follow-up after a first hospitalization with a diagnosis of a schizophrenia spectrum disorder: A retrospective population-based cohort study in Ontario, Canada.
    PLoS One. 2023;18:e0287334.
    >> Share

  44. SASAKI J, Muranaka S, Arahata K, Sato A, et al
    Developing and validating the Japanese version of the Referential Thinking Scale: A cross-sectional study.
    PLoS One. 2023;18:e0283416.
    >> Share

  45. GUNDOGMUS AG, Gerretsen P, Song J, Erdi Akdag F, et al
    Insight in schizophrenia is associated with psychoeducation and social support: Testing a new more comprehensive insight tool in Turkish schizophrenia patients.
    PLoS One. 2023;18:e0288177.
    >> Share

  46. ISLAM MK, Islam MR, Rahman MH, Islam MZ, et al
    Integrated bioinformatics and statistical approach to identify the cmmon mlecular mchanisms of oesity that are linked to the development of two psychiatric disorders: Schizophrenia and major depressive disorder.
    PLoS One. 2023;18:e0276820.
    >> Share

  47. CANESSA N, Iozzino L, Andreose S, Castelletti L, et al
    RISK aversion in Italian forensic and non-forensic patients with schizophrenia spectrum disorders.
    PLoS One. 2023;18:e0289152.
    >> Share

  48. MONTAZERI M, Moradi E, Moosazadeh M, Hosseini SH, et al
    Relationship between Toxoplasma gondii infection and psychiatric disorders in Iran: A systematic review with meta-analysis.
    PLoS One. 2023;18:e0284954.
    >> Share

  49. TAMENE FB, Sema FD, Sendekie AK
    Antipsychotic polypharmacy and associated factors among patients with schizophrenia: Multicenter cross-sectional study in Northwest Ethiopia.
    PLoS One. 2023;18:e0290037.
    >> Share

  50. RANDHAWA A, Kuhn S, Schottle D, Moritz S, et al
    The effects of assessing character strengths vs. psychopathology on mood, hope, perceived stigma and cognitive performance in individuals with psychosis.
    PLoS One. 2023;18:e0289872.
    >> Share

  51. CHAVES MF, Rodrigues C, Ribeiro S, Mota NB, et al
    Grammatical impairment in schizophrenia: An exploratory study of the pronominal and sentential domains.
    PLoS One. 2023;18:e0291446.
    >> Share

  52. AGARWAL SM, Dissanayake J, Agid O, Bowie C, et al
    Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
    PLoS One. 2023;18:e0288354.
    >> Share

  53. MARTZOUKOU M, Papadopoulos D, Kosmidis MH
    Syntactic and affective prosody recognition: Schizophrenia vs. Autism spectrum disorders.
    PLoS One. 2023;18:e0292325.
    >> Share

  54. JUCHNOWICZ D, Dzikowski M, Rog J, Waszkiewicz N, et al
    The usefulness of a complete blood count in the prediction of the first episode of schizophrenia diagnosis and its relationship with oxidative stress.
    PLoS One. 2023;18:e0292756.
    >> Share

  55. LYLES S, Khan Z, Qureshi O, Shaikh M, et al
    A systematic review of the effectiveness and implementation readiness of psychosocial interventions for psychosis in South Asia.
    PLoS One. 2023;18:e0283411.
    >> Share

  56. CLEMENTI L, Arnone E, Santambrogio MD, Franceschetti S, et al
    Anatomically compliant modes of variations: New tools for brain connectivity.
    PLoS One. 2023;18:e0292450.
    >> Share

  57. ABDIN E, Seet V, Jeyagurunathan A, Tan SC, et al
    Validation of the 12-item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore.
    PLoS One. 2023;18:e0294908.
    >> Share

  58. LAWRIE S, Hanlon C, Manda-Taylor L, Knapp M, et al
    Psychosis Recovery Orientation in Malawi by Improving Services and Engagement (PROMISE) protocol.
    PLoS One. 2023;18:e0293370.
    >> Share

    January 2022
  59. ADJORLOLO S, Mensah G, Badzi CD
    Psychosis risk among pregnant women in Ghana.
    PLoS One. 2022;17:e0263011.
    >> Share

  60. ABED-ESFAHANI P, Darwin BC, Howard D, Wang N, et al
    Evaluation of deep convolutional neural networks for in situ hybridization gene expression image representation.
    PLoS One. 2022;17:e0262717.
    >> Share

  61. DHUNGANA S, Tulachan P, Chapagai M, Pant SB, et al
    Internalized stigma in patients with schizophrenia: A hospital-based cross-sectional study from Nepal.
    PLoS One. 2022;17:e0264466.
    >> Share

  62. OKAZAKI S, Boku S, Watanabe Y, Otsuka I, et al
    Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia.
    PLoS One. 2022;17:e0265738.
    >> Share

  63. JIANG Z, Luskus M, Seyedi S, Griner EL, et al
    Utilizing computer vision for facial behavior analysis in schizophrenia studies: A systematic review.
    PLoS One. 2022;17:e0266828.
    >> Share

  64. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    >> Share

  65. LIAN L, Kim DD, Procyshyn RM, Cazares D, et al
    Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.
    PLoS One. 2022;17:e0267808.
    >> Share

  66. TOYAMA M, Takasaki Y, Branko A, Kimura H, et al
    Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels.
    PLoS One. 2022;17:e0268321.
    >> Share

  67. ALGUMAEI AH, Algunaid RF, Rushdi MA, Yassine IA, et al
    Feature and decision-level fusion for schizophrenia detection based on resting-state fMRI data.
    PLoS One. 2022;17:e0265300.
    >> Share

  68. FAULKNER SM, Drake RJ, Ogden M, Gardani M, et al
    A mixed methods expert opinion study on the optimal content and format for an occupational therapy intervention to improve sleep in schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0269453.
    >> Share

  69. ERSHOVA ES, Shmarina GV, Martynov AV, Zakharova NV, et al
    NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.
    PLoS One. 2022;17:e0269130.
    >> Share

  70. ADEME M, Kebede T, Teferra S, Alemayehu M, et al
    Is latent Toxoplasma gondii infection associated with the occurrence of schizophrenia? A case-control study.
    PLoS One. 2022;17:e0270377.
    >> Share

  71. BARBIC D, Whyte M, Sidhu G, Luongo A, et al
    One-year mortality of emergency department patients with substance-induced psychosis.
    PLoS One. 2022;17:e0270307.
    >> Share

  72. CHIEN TY, Chern JS, Wang SP, Yang Y, et al
    Effects of multitask training on cognition and motor control in people with schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0264745.
    >> Share

  73. YOSHIKAWA A, Kushima I, Miyashita M, Suzuki K, et al
    Exonic deletions in IMMP2L in schizophrenia with enhanced glycation stress subtype.
    PLoS One. 2022;17:e0270506.
    >> Share

  74. AKENA D, Semeere A, Kadama P, Mwesiga EK, et al
    Feasibility of conducting a pilot randomized control trial of a psycho-education intervention in patients with a first episode psychosis in Uganda-A study protocol.
    PLoS One. 2022;17:e0268493.
    >> Share

  75. GARGANO G, Caletti E, Perlini C, Turtulici N, et al
    Language production impairments in patients with a first episode of psychosis.
    PLoS One. 2022;17:e0272873.
    >> Share

  76. WYNN JK, McCleery A, Novacek DM, Reavis EA, et al
    The impact of the COVID-19 pandemic on mental health and functional outcomes in Veterans with psychosis or recent homelessness: A 15-month longitudinal study.
    PLoS One. 2022;17:e0273579.
    >> Share

  77. KHATTAK MI, Dikomitis L, Khan MF, Haq MU, et al
    Patients' and healthcare professionals' perspectives on a community-based intervention for schizophrenia in Pakistan: A focus group study.
    PLoS One. 2022;17:e0273286.
    >> Share

  78. KADRA-SCALZO G, Fonseca de Freitas D, Agbedjro D, Francis E, et al
    A predictor model of treatment resistance in schizophrenia using data from electronic health records.
    PLoS One. 2022;17:e0274864.
    >> Share

  79. AL-HAKEIM HK, Al-Musawi AF, Al-Mulla A, Al-Dujaili AH, et al
    The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis.
    PLoS One. 2022;17:e0275839.
    >> Share

  80. RAMOS-MASTACHE D, Mondragon-Maya A, Liemburg EJ, Enriquez-Geppert S, et al
    Understanding the relationship between apathy, cognition and functional outcome in schizophrenia: The significance of an ecological assessment.
    PLoS One. 2022;17:e0277047.
    >> Share

  81. JONES CJ, Hazell CM, Hayward M, Pandey A, et al
    Caring for Carers (C4C): Results from a feasibility randomised controlled trial of positive written disclosure for older adult carers of people with psychosis.
    PLoS One. 2022;17:e0277196.
    >> Share

  82. RAZZAK RA, Jahrami H, Husni M, Ali ME, et al
    Perceptual visual dependence for spatial orientation in patients with schizophrenia.
    PLoS One. 2022;17:e0278718.
    >> Share

  83. AL-NEMA M, Gaurav A, Lee MT, Okechukwu P, et al
    Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia.
    PLoS One. 2022;17:e0278216.
    >> Share

  84. JOHNSON T, Saatci D, Handunnetthi L
    Maternal immune activation induces methylation changes in schizophrenia genes.
    PLoS One. 2022;17:e0278155.
    >> Share

  85. MATHIS WS, Ferrara M, Burke S, Hyun E, et al
    Granular analysis of pathways to care and durations of untreated psychosis: A marginal delay model.
    PLoS One. 2022;17:e0270234.
    >> Share

  86. SOLER-VIDAL J, Fuentes-Claramonte P, Salgado-Pineda P, Ramiro N, et al
    Brain correlates of speech perception in schizophrenia patients with and without auditory hallucinations.
    PLoS One. 2022;17:e0276975.
    >> Share

  87. VAN DER STOUWE ECD, de Vries B, Steenhuis LA, Waarheid CO, et al
    BEATVIC, a body-oriented resilience therapy for individuals with psychosis: Short term results of a multi-center RCT.
    PLoS One. 2022;17:e0279185.
    >> Share

    January 2021
  88. HINOJOSA-MARQUES L, Monsonet M, Kwapil TR, Barrantes-Vidal N, et al
    The impact of family environment on self-esteem and symptoms in early psychosis.
    PLoS One. 2021;16:e0249721.
    >> Share

  89. MAKI S, Nagai K, Ando S, Tamakoshi K, et al
    Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study.
    PLoS One. 2021;16:e0250771.
    >> Share

  90. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    >> Share

  91. HAYASHI N, Igarashi Y, Harima H
    Delusion progression process from the perspective of patients with psychoses: A descriptive study based on the primary delusion concept of Karl Jaspers.
    PLoS One. 2021;16:e0250766.
    >> Share

  92. ROSEN DL, Travers D
    Emergency department visits among patients transported by law enforcement officers.
    PLoS One. 2021;16:e0244679.
    >> Share

  93. KIM K, Duc NT, Choi M, Lee B, et al
    EEG microstate features for schizophrenia classification.
    PLoS One. 2021;16:e0251842.
    >> Share

  94. KRONBICHLER L, Stelzig-Scholer R, Lenger M, Weber S, et al
    Preserved intention understanding during moral judgments in schizophrenia.
    PLoS One. 2021;16:e0251180.
    >> Share

  95. LINCOLN SH, Johnson T, Kim S, Edenbaum E, et al
    Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
    PLoS One. 2021;16:e0251753.
    >> Share

  96. KOBORI A, Miyashita M, Miyano Y, Suzuki K, et al
    Advanced glycation end products and cognitive impairment in schizophrenia.
    PLoS One. 2021;16:e0251283.
    >> Share

  97. KURUKGY JL, Bourgin J, Benoit JP, Guessoum SB, et al
    Implementing organicity investigations in early psychosis: Spreading expertise.
    PLoS One. 2021;16:e0252610.
    >> Share

  98. NOROVSAMBUU O, Tsend-Ayush A, Lkhagvasuren N, Jav S, et al
    Main characteristics of dermatoglypics associated with schizophrenia and its clinical subtypes.
    PLoS One. 2021;16:e0252831.
    >> Share

  99. SCHILLING TM, Bossert M, Konig M, Wirtz G, et al
    Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia-A randomized controlled trial.
    PLoS One. 2021;16:e0254695.
    >> Share

  100. HUCKLE C, Lemmel F, Johnson S
    Experiences of friendships of young people with first-episode psychosis: A qualitative study.
    PLoS One. 2021;16:e0255469.
    >> Share

  101. SHOR O, Glik A, Yaniv-Rosenfeld A, Valevski A, et al
    EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline.
    PLoS One. 2021;16:e0255529.
    >> Share

  102. JUNG YS, Kim YE, Go DS, Yoon SJ, et al
    The prevalence, incidence, and admission rate of diagnosed schizophrenia spectrum disorders in Korea, 2008-2017: A nationwide population-based study using claims big data analysis.
    PLoS One. 2021;16:e0256221.
    >> Share

  103. SHIMIZU J, Kuwata H, Kuwata K
    Differences in fractal patterns and characteristic periodicities between word salads and normal sentences: Interference of meaning and sound.
    PLoS One. 2021;16:e0247133.
    >> Share

  104. DUTRA-TAVARES AC, Manhaes AC, Semeao KA, Maia JG, et al
    Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model.
    PLoS One. 2021;16:e0257986.
    >> Share

  105. MARTIN J, Asjadi K, Hubbard L, Kendall K, et al
    Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.
    PLoS One. 2021;16:e0248254.
    >> Share

  106. DOYEN S, Taylor H, Nicholas P, Crawford L, et al
    Hollow-tree super: A directional and scalable approach for feature importance in boosted tree models.
    PLoS One. 2021;16:e0258658.
    >> Share

  107. DESALEGN D, Abdu Z, Hajure M
    Prevalence of tobacco dependence and associated factors among patients with schizophrenia attending their treatments at southwest Ethiopia; hospital-based cross-sectional study.
    PLoS One. 2021;16:e0261154.
    >> Share

  108. WOLDEKIDAN NA, Mohammed AS, Degu A, Tadiwos Y, et al
    Prevalence of metabolic syndrome and associated factors among psychiatric patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    PLoS One. 2021;16:e0256195.
    >> Share

  109. SAKURAI K, Itou T, Morita M, Kasahara E, et al
    Effects of Importin alpha1/KPNA1 deletion and adolescent social isolation stress on psychiatric disorder-associated behaviors in mice.
    PLoS One. 2021;16:e0258364.
    >> Share

  110. ZANDER-SCHELLENBERG T, Kuhn SAK, Moller J, Meyer AH, et al
    Is intuition allied with jumping to conclusions in decision-making? An intensive longitudinal study in patients with delusions and in non-clinical individuals.
    PLoS One. 2021;16:e0261296.
    >> Share

  111. LEE GS, Zhang J, Wu Y, Zhou Y, et al
    14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons.
    PLoS One. 2021;16:e0261791.
    >> Share

  112. HAYAKAWA T, Terahara M, Fujito NT, Matsunaga T, et al
    Lower promoter activity of the ST8SIA2 gene has been favored in evolving human collective brains.
    PLoS One. 2021;16:e0259897.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016